Cargando…

Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study

SUMMARY: This multi-center, prospective, open-label, observational study evaluated the effects of once-monthly minodronate (50 mg) on treatment persistence, bone turnover markers, bone mineral density, low back pain, and upper gastrointestinal symptoms in outpatients with osteoporosis previously tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakai, A., Ikeda, S., Okimoto, N., Matsumoto, H., Teshima, K., Okazaki, Y., Fukuda, F., Arita, S., Tsurukami, H., Nagashima, M., Yoshioka, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134483/ https://www.ncbi.nlm.nih.gov/pubmed/24899103 http://dx.doi.org/10.1007/s00198-014-2756-8

Ejemplares similares

Erratum to: Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study
por: Sakai, A., et al.
Publicado: (2014)

Influence on the bone mineral density and bone metabolism marker after the interruption and reinitiation of monthly minodronate therapy in postmenopausal women with osteoporosis
por: Okimoto, Nobukazu, et al.
Publicado: (2018)

Unsatisfied
Publicado: (1890)

Minodronate for the treatment of osteoporosis
por: Ohishi, Tsuyoshi, et al.
Publicado: (2018)

Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis
por: Okazaki, R., et al.
Publicado: (2011)

A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo
por: Sato, K, et al.
Publicado: (2006)

The entropy principle: thermodynamics for the unsatisfied
por: Thess, André, et al.
Publicado: (2011)

Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
por: Eekman, Danielle A, et al.
Publicado: (2011)

Approximate Counting of Minimal Unsatisfiable Subsets
por: Bendík, Jaroslav, et al.
Publicado: (2020)

Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open‐label, prospective, observational study
por: Okimoto, Nobukazu, et al.
Publicado: (2018)

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis
por: Hasegawa, Eriko, et al.
Publicado: (2018)

MUST: Minimal Unsatisfiable Subsets Enumeration Tool
por: Bendík, Jaroslav, et al.
Publicado: (2020)

Three years of treatment with minodronate in patients with postmenopausal osteoporosis
por: Hagino, Hiroshi, et al.
Publicado: (2011)

A review of minodronic acid hydrate for the treatment of osteoporosis
por: Tanishima, Shinji, et al.
Publicado: (2013)

Abstract 2. Salvage Ear Reconstruction of the Unsatisfied Patient
por: Reinisch, John, et al.
Publicado: (2017)

BISPHOSPHONATE-INDUCED MAXILLOFACIAL OSTEONECROSIS IN OSTEOPOROTIC INDIVIDUALS
por: da Silva Santos, Paulo Sérgio, et al.
Publicado: (2015)

Minodronate in the treatment of osteoporosis: A systematic review and meta-analysis
por: Liu, Qingshan, et al.
Publicado: (2020)

Drug-induced hypersensitivity syndrome caused by minodronic acid hydrate
por: Muto, Yutaka, et al.
Publicado: (2021)

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study
por: Matsumoto, T., et al.
Publicado: (2008)

Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Erratum to: Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis
por: Sakai, A., et al.
Publicado: (2015)

Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis
por: Sakai, A., et al.
Publicado: (2015)

Unsatisfied patient’s rights: A survey on the views of patients, nurses and physicians
por: Parsapoor¹, Alireza, et al.
Publicado: (2012)

Unsatisfied contraceptive preferences due to cost among women in the United States()
por: Burke, Kristen Lagasse, et al.
Publicado: (2020)

Unsatisfying mitral valve repair? The “Loop method”: a lifebelt to grab
por: Loardi, Claudia, et al.
Publicado: (2021)

The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis
por: Byun, Ji-Hye, et al.
Publicado: (2017)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

COVID-19 vaccination in Africa: A case of unsatisfied expectation and ill-preparedness
por: Ekwebelem, Osmond C., et al.
Publicado: (2022)

Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype
por: Tummolo, Albina, et al.
Publicado: (2013)

Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis
por: Strauß, Theresa, et al.
Publicado: (2022)

Biomechanical comparison of lag screw and non-spiral blade fixation of a novel femoral trochanteric nail in an osteoporotic bone model
por: Fuse, Yoshifumi, et al.
Publicado: (2022)

Protein sequence optimization with a pairwise decomposable penalty for buried unsatisfied hydrogen bonds
por: Coventry, Brian, et al.
Publicado: (2021)

Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials
por: Hirota, Masashi, et al.
Publicado: (2021)

Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer
por: Chen, Chen, et al.
Publicado: (2021)

FRI291 Musashi1 And Musashi2 Mark Distinct Pituitary Stem Cell Populations
por: Rahmatallah, Yasir, et al.
Publicado: (2023)

Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
por: Iwamoto, Jun, et al.
Publicado: (2014)

The effects of bisphosphonates on osteoporotic patients after lumbar fusion: a meta-analysis
por: Liu, Wen-bin, et al.
Publicado: (2018)

Potential unsatisfiability of cyclic constraints on stochastic biological networks biases selection towards hierarchical architectures
por: Smith, Cameron, et al.
Publicado: (2015)

Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics
por: Kwon, Jun Soo, et al.
Publicado: (2015)

Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
por: Kamimura, Mikio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6jqecn0qi6r4a9tvnubd60lbev